<![CDATA[IMDZ Immune Design Corp(NASDAQ:IMDZ)]]>

<![CDATA[IMDZ Immune Design Corp(NASDAQ:IMDZ)]]>Totalt oversolgt.

2-3 dollars rebound muligt. Target 8.

Så er der lagt i kakkelovnen.

Ingen anbefalinger. Mine handler.

]]>https://dev.proinvestor.com/forum/topic/439751/imdz-immune-design-corpnasdaqimdzRSS for NodeFri, 17 Jul 2026 14:21:21 GMTFri, 20 Oct 2017 06:19:36 GMT60<![CDATA[Reply to IMDZ Immune Design Corp(NASDAQ:IMDZ) on Fri, 20 Oct 2017 06:35:43 GMT]]>Immune Design (Nasdaq: IMDZ) 4.5% HIGHER; announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation for G100, Immune Designs investigational intratumoral therapy, for the treatment of follicular non-Hodgkins lymphoma.

]]>https://dev.proinvestor.com/forum/post/9452663https://dev.proinvestor.com/forum/post/9452663Fri, 20 Oct 2017 06:35:43 GMT